Wednesday, November 17, 2021 4:14:16 PM
This means that while insurance pays 25-30% (that part is negotiated and yes, lower than out of network in price) of the bill, the rest is left to the client to pay themselves.
Now in network is not all bad, ARIA being in a network means that insurers will funnel clients towards ARIA due to their discount deal.
This still means that unless there is issues with the standard healthcare drama of people refusing to pay their bills (more unlikely in a detox center people willingly sign up for than an ER ward that people end up in after a car accident), ARIA should be able to collect most of that 600k.
Unless you can find me actual information on the fact that ARIA offers its rooms for pennies, this is one more absolutely baseless fear mongering tactic from you.
I find it curious how you keep slipping up, last time it was Wake making you "remember" about the Canadian lease.
So your only leg to stand on is an old "story" (see I can do that too) about outdated filings that didn't show any revenue and dilutive debt that is becoming less and less relevant by the day.
Please keep to your earning reports nitpicking, it's clearly the only thing you can understand correctly and you slip up each time you go out of that area of comfort
Recent GRST News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/07/2024 09:45:09 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 12/22/2023 09:54:23 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 12/22/2023 09:04:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:55:26 PM
- Form 1-A POS - • Edgar (US Regulatory) • 10/20/2023 07:29:40 PM
- Form 1-A POS - • Edgar (US Regulatory) • 08/29/2023 07:21:19 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 08:37:36 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 12:43:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/11/2023 04:51:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/18/2023 06:56:41 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM